FDA — authorised 9 February 1939
- Application: NDA000552
- Marketing authorisation holder: ASPEN GLOBAL INC
- Local brand name: LIQUAEMIN SODIUM
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Heparin Sodium In Plastic Container in United States
FDA authorised Heparin Sodium In Plastic Container on 9 February 1939
Marketing authorisations
FDA — authorised 5 February 1942
- Application: NDA004570
- Marketing authorisation holder: PHARMACIA AND UPJOHN
- Local brand name: HEPARIN SODIUM
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 4 May 1943
- Application: NDA005264
- Marketing authorisation holder: HOSPIRA
- Local brand name: HEPARIN SODIUM PRESERVATIVE FREE
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 19 May 1944
- Application: NDA005521
- Marketing authorisation holder: LILLY
- Local brand name: HEPARIN SODIUM
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 22 February 1972
- Application: NDA017029
- Marketing authorisation holder: FRESENIUS KABI USA
- Local brand name: HEPARIN SODIUM PRESERVATIVE FREE
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 28 May 1974
- Application: NDA017007
- Marketing authorisation holder: HIKMA
- Local brand name: HEPARIN SODIUM
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 22 November 1974
- Application: NDA017064
- Marketing authorisation holder: DR REDDYS
- Local brand name: HEPARIN SODIUM
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 10 December 1975
- Application: NDA017486
- Marketing authorisation holder: EPIC PHARMA LLC
- Local brand name: HEPARIN SODIUM
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 10 February 1978
- Application: NDA017651
- Marketing authorisation holder: FRESENIUS KABI USA
- Local brand name: HEPARIN SODIUM
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 21 April 1978
- Application: NDA017780
- Marketing authorisation holder: PHARM SPEC
- Local brand name: HEPARIN SODIUM
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 21 December 1978
- Application: NDA017979
- Marketing authorisation holder: ABRAXIS PHARM
- Local brand name: HEPARIN SODIUM
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 13 March 1979
- Application: ANDA086357
- Marketing authorisation holder: INTL MEDICATION
- Local brand name: HEPARIN LOCK FLUSH
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 22 February 1980
- Application: ANDA086129
- Marketing authorisation holder: PHARMA SERVE NY
- Local brand name: HEPARIN SODIUM PRESERVATIVE FREE
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 28 April 1982
- Application: NDA018609
- Marketing authorisation holder: BAXTER HLTHCARE
- Local brand name: HEPARIN SODIUM 1,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 31 January 1984
- Application: NDA018916
- Marketing authorisation holder: HOSPIRA
- Local brand name: HEPARIN SODIUM 10,000 UNITS IN SODIUM CHLORIDE 0.9%
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 30 January 1985
- Application: NDA018911
- Marketing authorisation holder: HOSPIRA
- Local brand name: HEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.9%
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 29 March 1985
- Application: NDA019135
- Marketing authorisation holder: B BRAUN
- Local brand name: HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 3 June 1986
- Application: ANDA089464
- Marketing authorisation holder: DR REDDYS
- Local brand name: HEPARIN SODIUM PRESERVATIVE FREE
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 20 July 1992
- Application: NDA019953
- Marketing authorisation holder: B BRAUN
- Local brand name: HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 20 July 1992
- Application: NDA019952
- Marketing authorisation holder: B BRAUN
- Local brand name: HEPARIN SODIUM 20,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 1 December 1993
- Application: ANDA088100
- Marketing authorisation holder: HOSPIRA
- Indication: Manufacturing (CMC)
- Status: approved
FDA — authorised 10 October 1995
- Application: ANDA040008
- Marketing authorisation holder: WATSON LABS INC
- Local brand name: HEPARIN SODIUM
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 7 June 1996
- Application: ANDA040007
- Marketing authorisation holder: DR REDDYS
- Local brand name: HEPARIN SODIUM
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 31 August 2009
- Application: ANDA090571
- Marketing authorisation holder: HOSPIRA INC
- Local brand name: HEPARIN SODIUM
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 30 June 2010
- Application: ANDA090810
- Marketing authorisation holder: SAGENT PHARMS
- Local brand name: HEPARIN SODIUM PRESERVATIVE FREE
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 8 June 2011
- Application: ANDA201002
- Marketing authorisation holder: PLANO PHARMS
- Local brand name: HEPARIN SODIUM
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 12 June 2014
- Application: ANDA203198
- Marketing authorisation holder: SHENZHEN TECHDOW
- Local brand name: HEPARIN SODIUM
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 12 June 2014
- Application: ANDA202732
- Marketing authorisation holder: SHENZHEN TECHDOW
- Local brand name: HEPARIN SODIUM PRESERVATIVE FREE
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 12 June 2014
- Application: ANDA202957
- Marketing authorisation holder: SHENZHEN TECHDOW
- Local brand name: HEPARIN SODIUM
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 10 June 2016
- Application: ANDA206552
- Marketing authorisation holder: FRESENIUS KABI USA
- Status: approved
FDA — authorised 6 February 2017
- Application: ANDA205323
- Marketing authorisation holder: GLAND
- Status: approved
FDA — authorised 14 December 2018
- Application: ANDA211005
- Marketing authorisation holder: EMERGE BIOSCIENCE
- Local brand name: HEPARIN SODIUM
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 28 May 2019
- Application: ANDA211007
- Marketing authorisation holder: EMERGE BIOSCIENCE
- Local brand name: HEPARIN SODIUM
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 24 February 2020
- Application: ANDA211004
- Marketing authorisation holder: EMERGE BIOSCIENCE
- Local brand name: HEPARIN SODIUM
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 2 April 2020
- Application: ANDA212060
- Marketing authorisation holder: EMERGE BIOSCIENCE
- Local brand name: HEPARIN SODIUM PRESERVATIVE FREE
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 15 July 2020
- Application: ANDA212061
- Marketing authorisation holder: EMERGE BIOSCIENCE
- Local brand name: HEPARIN SODIUM
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 24 July 2020
- Application: ANDA212441
- Marketing authorisation holder: FRESENIUS KABI USA
- Local brand name: HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 29 July 2020
- Application: ANDA203851
- Marketing authorisation holder: PHARMOBEDIENT
- Indication: Labeling
- Status: approved
FDA — authorised 29 December 2020
- Application: ANDA214839
- Marketing authorisation holder: BE PHARMS
- Local brand name: HEPARIN SODIUM
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 29 December 2020
- Application: ANDA214804
- Marketing authorisation holder: BE PHARMS
- Local brand name: HEPARIN SODIUM
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA
- Application: NDA017027
- Marketing authorisation holder: 3M
- Local brand name: LIPO-HEPIN
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA
- Application: ANDA087043
- Marketing authorisation holder: SOLOPAK
- Local brand name: HEPARIN SODIUM
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA
- Application: NDA017130
- Marketing authorisation holder: CHAMBERLIN PARENTERL
- Local brand name: HEPARIN SODIUM
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA
- Application: NDA019130
- Marketing authorisation holder: MCGAW
- Local brand name: HEPARIN SODIUM 1,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA
- Application: ANDA088580
- Marketing authorisation holder: SMITH AND NEPHEW
- Local brand name: HEPARIN LOCK FLUSH
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA
- Application: ANDA087905
- Marketing authorisation holder: SOLOPAK
- Local brand name: HEPARIN LOCK FLUSH
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA
- Application: ANDA087906
- Marketing authorisation holder: SMITH AND NEPHEW
- Local brand name: HEPARIN LOCK FLUSH
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA
- Application: ANDA088239
- Marketing authorisation holder: SMITH AND NEPHEW
- Local brand name: HEPARIN SODIUM
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA
- Application: NDA017033
- Marketing authorisation holder: ABRAXIS PHARM
- Local brand name: HEPARIN SODIUM
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA
- Application: ANDA087904
- Marketing authorisation holder: SMITH AND NEPHEW
- Local brand name: HEPARIN LOCK FLUSH
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA
- Application: ANDA087903
- Marketing authorisation holder: SOLOPAK
- Local brand name: HEPARIN LOCK FLUSH
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA
- Application: ANDA088581
- Marketing authorisation holder: SMITH AND NEPHEW
- Local brand name: HEPARIN LOCK FLUSH
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA
- Application: ANDA087077
- Marketing authorisation holder: SOLOPAK
- Local brand name: HEPARIN SODIUM
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA
- Application: ANDA087959
- Marketing authorisation holder: SMITH AND NEPHEW
- Local brand name: HEPARIN LOCK FLUSH
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA
- Application: ANDA087958
- Marketing authorisation holder: SMITH AND NEPHEW
- Local brand name: HEPARIN LOCK FLUSH
- Indication: INJECTABLE — INJECTION
- Status: approved
Heparin Sodium In Plastic Container in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Heparin Sodium In Plastic Container approved in United States?
Yes. FDA authorised it on 9 February 1939; FDA authorised it on 5 February 1942; FDA authorised it on 4 May 1943.
Who is the marketing authorisation holder for Heparin Sodium In Plastic Container in United States?
ASPEN GLOBAL INC holds the US marketing authorisation.